Proto Labs (NYSE:PRLB – Get Free Report) issued an update on its third quarter earnings guidance on Friday morning. The company provided earnings per share (EPS) guidance of $0.29-0.37 for the period, compared to the consensus estimate of $0.41. The company issued revenue guidance of $117-125 million, compared to the consensus revenue estimate of $129.62 million. Proto Labs also updated its Q3 2024 guidance to 0.290-0.370 EPS.
Proto Labs Stock Performance
Shares of PRLB opened at $28.39 on Friday. The company has a market capitalization of $718.83 million, a P/E ratio of 36.87 and a beta of 1.33. The business’s 50-day moving average is $31.58 and its two-hundred day moving average is $33.41. Proto Labs has a fifty-two week low of $23.01 and a fifty-two week high of $41.87.
Proto Labs (NYSE:PRLB – Get Free Report) last posted its earnings results on Friday, May 3rd. The industrial products company reported $0.20 EPS for the quarter, topping the consensus estimate of $0.13 by $0.07. The firm had revenue of $127.89 million for the quarter, compared to analyst estimates of $123.81 million. Proto Labs had a return on equity of 2.88% and a net margin of 3.92%. Analysts forecast that Proto Labs will post 0.69 EPS for the current year.
Wall Street Analyst Weigh In
View Our Latest Report on Proto Labs
About Proto Labs
Proto Labs, Inc, together with its subsidiaries, operates as a digital manufacturer of custom parts in the United States and Europe. The company offers injection molding; computer numerical control machining; three-dimensional printing; and sheet metal fabrication products. It serves developers and engineers, who use 3D computer-aided design software to design products across a range of end-markets.
Read More
- Five stocks we like better than Proto Labs
- What is MarketRank� How to Use it
- Market Crash? No Problem for DoorDash Stock’s Impressive Earnings
- How to Evaluate a Stock Before BuyingÂ
- Snap’s Stock Plummets on Q2 Revenue Guidance Shortfall
- Airline Stocks – Top Airline Stocks to Buy Now
- Hims & Hers Stock Falls on DexCom Fears: Analysts Predict Rally
Receive News & Ratings for Proto Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Proto Labs and related companies with MarketBeat.com's FREE daily email newsletter.